A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHALMALI GLUE IN THE MANAGEMENT OF INCISED WOUND.”
试验速览
- 阶段
- 1/2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
This study is a randomized, open-label, comparative clinical trial designed to evaluate the efficacy and safety of Shalmali glue (Bombax ceiba gum) in the management of incised wounds. A total of 40 patients aged 15–60 years with fresh incised wounds (within 6 hours of injury) will be randomly allocated into two groups. Group A will receive topical application of Shalmali glue, and Group B will receive Dermabond glue as an active control.Wound healing will be assessed using objective parameters including redness, edema, ecchymosis, discharge, and wound approximation, along with pain assessment using the Visual Analogue Scale (VAS). Follow-up will be conducted on Day 3, Day 5, and Day 7. The study aims to determine whether Shalmali glue can serve as a safe and effective alternative to Dermabond for wound closure.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 15.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient with giving informed written consent.
- •Patient aged between 15 to 60 years.
- •Patients having incised wound of maximum length 5 cm and depth facia.
- •Patients having maximum 6 hours of duration of Vrana.
- •Patients without any complications.
排除标准
- •Patients suffering from Dustavrana (non healing wounds) Patients with infection and malignant wounds will be excluded from the study.
- •Patients having deeper wound tearing muscle beneath.
- •Patients having profuse bleeding due to injury.
- •Patients having major complications like diabetes mellitus, varicose veins.
- •HIV, HBsAg , VDRL Positive patient.
研究者
Dr SNEH R RATHOD
Parul institute of Ayurved